BHC vs. VRX, APHA, TLRY, CRON, THCX, WEED, GUD, ACB, FIRE, and EPI
Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Valeant Pharmaceuticals International (VRX), Aphria (APHA), Tilray Brands (TLRY), Cronos Group (CRON), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), and ESSA Pharma (EPI). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Bausch Health Companies (TSE:BHC) and Valeant Pharmaceuticals International (TSE:VRX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and dividends.
Valeant Pharmaceuticals International received 427 more outperform votes than Bausch Health Companies when rated by MarketBeat users. However, 66.10% of users gave Bausch Health Companies an outperform vote while only 65.27% of users gave Valeant Pharmaceuticals International an outperform vote.
80.0% of Bausch Health Companies shares are owned by institutional investors. 0.9% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Bausch Health Companies presently has a consensus price target of C$9.00, indicating a potential upside of 4.29%. Given Bausch Health Companies' higher probable upside, equities research analysts clearly believe Bausch Health Companies is more favorable than Valeant Pharmaceuticals International.
Valeant Pharmaceuticals International has a net margin of 0.00% compared to Bausch Health Companies' net margin of -5.07%. Valeant Pharmaceuticals International's return on equity of 0.00% beat Bausch Health Companies' return on equity.
Valeant Pharmaceuticals International has lower revenue, but higher earnings than Bausch Health Companies.
In the previous week, Bausch Health Companies' average media sentiment score of 0.00 equaled Valeant Pharmaceuticals International'saverage media sentiment score.
Summary
Bausch Health Companies beats Valeant Pharmaceuticals International on 6 of the 9 factors compared between the two stocks.
Get Bausch Health Companies News Delivered to You Automatically
Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bausch Health Companies Competitors List
Related Companies and Tools
